Skip to main content
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Mar;4(2):217–222. doi: 10.1128/cdli.4.2.217-222.1997

CD69 expression reliably predicts the anti-CD3-induced proliferative response of lymphocytes from human immunodeficiency virus type 1-infected patients.

H E Prince 1, M Lapé-Nixon 1
PMCID: PMC170505  PMID: 9067659

Abstract

Published studies suggest that mitogenic responses of lymphocytes can be reliably assessed by monitoring the expression of lymphocyte surface CD69 after 24 h of culture with the stimulant. We tested this hypothesis by determining the ability of lymphocyte CD69 expression to predict the outcome (normal or abnormal) of lymphocyte proliferative responses to anti-CD3 in a group of human immunodeficiency virus type 1 (HIV-1)-infected patients (n = 47). Cutoff values for defining normal and abnormal CD69 expression and proliferative ([3H]thymidine incorporation) responses were established with lymphocytes from healthy uninfected controls (n = 20). Lymphocytes from 29 HIV-infected patients exhibited an abnormal proliferative response, and those from 25 of the 29 also exhibited abnormal CD69 expression (sensitivity, 86.2%). Similarly, lymphocytes from 18 HIV-infected patients exhibited a normal proliferative response, and those from 16 of the 18 also exhibited normal CD69 expression (specificity, 88.9%). The predictive value of a normal CD69 result was 80%, and the predictive value of an abnormal CD69 result was 92.6%. These findings demonstrate that HIV-1-associated impairments in lymphocyte activation can be reliably detected by the rapid and nonradioactive CD69 expression assay.

Full Text

The Full Text of this article is available as a PDF (104.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang T. W. Induction of T cell proliferation and lymphokine production by monoclonal antibody. Lymphokine Res. 1982;1(1):5–8. [PubMed] [Google Scholar]
  2. Ciobanu N., Welte K., Kruger G., Venuta S., Gold J., Feldman S. P., Wang C. Y., Koziner B., Moore M. A., Safai B. Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2. J Clin Immunol. 1983 Oct;3(4):332–340. doi: 10.1007/BF00915794. [DOI] [PubMed] [Google Scholar]
  3. Gibbons D. C., Evans T. G. CD69 expression after antigenic stimulation. Cytometry. 1996 Mar 1;23(3):260–261. doi: 10.1002/cyto.990230302. [DOI] [PubMed] [Google Scholar]
  4. Giorgi J. V., Detels R. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. Clin Immunol Immunopathol. 1989 Jul;52(1):10–18. doi: 10.1016/0090-1229(89)90188-8. [DOI] [PubMed] [Google Scholar]
  5. Hara T., Jung L. K., Bjorndahl J. M., Fu S. M. Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens. J Exp Med. 1986 Dec 1;164(6):1988–2005. doi: 10.1084/jem.164.6.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Krowka J. F., Cuevas B., Maron D. C., Steimer K. S., Ascher M. S., Sheppard H. W. Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jan 1;11(1):95–104. doi: 10.1097/00042560-199601010-00013. [DOI] [PubMed] [Google Scholar]
  7. Maino V. C., Suni M. A., Ruitenberg J. J. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry. 1995 Jun 1;20(2):127–133. doi: 10.1002/cyto.990200205. [DOI] [PubMed] [Google Scholar]
  8. Margolick J. B., Donnenberg A. D., Muñoz A., Park L. P., Bauer K. D., Giorgi J. V., Ferbas J., Saah A. J. Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 1993 Feb;6(2):153–161. [PubMed] [Google Scholar]
  9. Miedema F., Petit A. J., Terpstra F. G., Schattenkerk J. K., de Wolf F., Al B. J., Roos M., Lange J. M., Danner S. A., Goudsmit J. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest. 1988 Dec;82(6):1908–1914. doi: 10.1172/JCI113809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Oettgen H. C., Terhorst C. The T-cell receptor-T3 complex and T-lymphocyte activation. Hum Immunol. 1987 Mar;18(3):187–204. doi: 10.1016/0198-8859(87)90084-x. [DOI] [PubMed] [Google Scholar]
  11. Prince H. E., John J. K. Unique pattern of interleukin 2 receptor expression by lymphocytes in response to anti-Leu 4 monoclonal antibody: relationship to monocyte accessory cell function. Diagn Immunol. 1986;4(5):241–246. [PubMed] [Google Scholar]
  12. Roos M. T., Miedema F., Koot M., Tersmette M., Schaasberg W. P., Coutinho R. A., Schellekens P. T. T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J Infect Dis. 1995 Mar;171(3):531–536. doi: 10.1093/infdis/171.3.531. [DOI] [PubMed] [Google Scholar]
  13. Simms P. E., Ellis T. M. Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin Diagn Lab Immunol. 1996 May;3(3):301–304. doi: 10.1128/cdli.3.3.301-304.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Testi R., Phillips J. H., Lanier L. L. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C. J Immunol. 1989 Mar 15;142(6):1854–1860. [PubMed] [Google Scholar]
  15. Testi R., Phillips J. H., Lanier L. L. T cell activation via Leu-23 (CD69). J Immunol. 1989 Aug 15;143(4):1123–1128. [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES